Initiative is part of the BMS Foundation commitment to health equity and diversity and inclusion made last year
Applications are also now open for second cohort to begin in October 2022
PRINCETON, N.J.–(BUSINESS WIRE)– The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced the first group of 52 physicians selected for its Diversity in Clinical Trials Career Development Program (BMSF DCTCDP). The 52 early-stage investigators are the first of 250 community-oriented clinical trialists who will be trained through the program by 2027. This initial cohort includes Dr. Ugonma Chukwueke of the Dana-Farber Cancer Institute.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211020005111/en/